CRST: The Podcast
06.20.25
In this episode, Drs. Waring and Chu share clinical insights and real-world experience from the first year of using the Teneo 317 excimer laser for correcting myopia and myopic astigmatism. As the first excimer platform to receive FDA approval in over 15 years, the Teneo 317 introduces modern performance to U.S. practices with its compact design, fast ablation speed, and intuitive user interface. The conversation covers key findings from the FDA clinical trial and early post-market use, including exceptional visual acuity outcomes, improved night vision, and high levels of patient satisfaction.
Sponsored by Bausch + Lomb
©2025 Bausch + Lomb TEN.0014.USA.25
View full description +
Subscribe
08.13.26
Evidence-Based Guidelines for KLEx: Translating a Global Expert Consensus Into Clinical Practice, Part 2Sonny Goel, MD; and Robert T. Lin, MD
08.13.26
Evidence-Based Guidelines for KLEx: Translating a Global Expert Consensus Into Clinical Practice, Part 1John F. Doane, MD, FACS; Sonny Goel, MD; and Robert T. Lin, MD
08.05.26
Rethinking the Drop with iDose TR: Patient ConversationsSavak Teymoorian, MD, MBA; Courtney Bovee, MD; and J. David Stephens, MD
Sponsored by Glaukos
07.08.26
Rethinking the Drop with iDose TR: Practice ImplementationChristine M. Funke, MD; Zarmeena Vendal, MD; and Lisa K. Feulner, MD, PhD
Sponsored by Glaukos
06.30.26
UNITYtime Podcast Episode 1: Real-World Experience with UNITY® VCS | CSAshley Brissette, MD, MSc, FRCSC; and Matthew Rauen, MD
Sponsored by Alcon
06.04.26
Refractive Lens Exchange and the Evolving Surgical Management of PresbyopiaGeorge O. Waring IV, MD, FACS; and Dagny C. Zhu, MD
06.03.26
Rethinking the Drop with iDose TR: Patient AccessI. Paul Singh, MD; Deborah Ristvedt, DO; and Kevin Talbot, MD
Sponsored by Glaukos
Show More